Form 4 Filing: Feuchtwang Ilan Acquires (Grant) shares of $CTKB

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

Cytek Biosciences, Inc.

Ticker: $CTKB

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-11-09

Shares: 25,745

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Feuchtwang Ilan, holds the title of Chief Legal Officer, Secretary at Cytek Biosciences, Inc..

On 2026-11-09, the insider transacted 25,745 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Feuchtwang Ilan (Chief Legal Officer, Secretary) was granted $0 of $CTKB

Post-Transaction Position: 25,745 shares

SEC Accession No: 0002141966-26-000004 (CIK: 2141966)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$CTKB Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$CTKB News Coverage